N(6)-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development

N(6)-Methyladenosine (m(6)A) modification is the most pervasive modification of human mRNA molecules. It is reversible via regulation of m(6)A modification methyltransferase, demethylase and proteins that preferentially recognize m(6)A modification as “writers”, “erasers” and “readers”, respectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Yi, Wan, Arabella, Lin, Ziyou, Lu, Xiongbin, Wan, Guohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251950/
https://www.ncbi.nlm.nih.gov/pubmed/30505654
http://dx.doi.org/10.1016/j.apsb.2018.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251950/
https://www.ncbi.nlm.nih.gov/pubmed/30505654
http://dx.doi.org/10.1016/j.apsb.2018.06.001

Ejemplares similares